Back to results
US 10,473,647 B1Granted
Peptides for use in treatment and diagnosis of type 1 diabetes
AssigneeImmusanT, Inc.
InventorRobert P. Anderson
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for treating autoimmune diabetes such as type 1 diabetes (T1D), diagnosing autoimmune diabetes such as T1D, assessing treatment efficacy, and selecting subjects for treatment, e.g., using a peptide or epitope disclosed.
Claims12
A composition, comprising a peptide, the peptide comprising the amino acid sequence GRTGTYILIDMVLNRMA (SEQ ID NO:
- 12), or at least one T cell epitope contained within the amino acid sequence,
- wherein the peptide is no more than 50 amino acids in length, and
- wherein the peptide comprises a modification on the N-terminus and/or C-terminus.
Dependencies are inferred from the claim text.